Frailty trajectories in three longitudinal studies of aging: Is the level or the rate of change more predictive of mortality?Show others and affiliations
2021 (English)In: Age and Ageing, ISSN 0002-0729, E-ISSN 1468-2834, Vol. 50, no 6, p. 2174-2182Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: frailty shows an upward trajectory with age, and higher levels increase the risk of mortality. However, it is less known whether the shape of frailty trajectories differs by age at death or whether the rate of change in frailty is associated with mortality.
OBJECTIVES: to assess population frailty trajectories by age at death and to analyse whether the current level of the frailty index (FI) i.e. the most recent measurement or the person-specific rate of change is more predictive of mortality.
METHODS: 3,689 individuals from three population-based cohorts with up to 15 repeated measurements of the Rockwood frailty index were analysed. The FI trajectories were assessed by stratifying the sample into four age-at-death groups: <70, 70-80, 80-90 and >90 years. Generalised survival models were used in the survival analysis.
RESULTS: the FI trajectories by age at death showed that those who died at <70 years had a steadily increasing trajectory throughout the 40 years before death, whereas those who died at the oldest ages only accrued deficits from age ~75 onwards. Higher level of FI was independently associated with increased risk of mortality (hazard ratio 1.68, 95% confidence interval 1.47-1.91), whereas the rate of change was no longer significant after accounting for the current FI level. The effect of the FI level did not weaken with time elapsed since the last measurement.
CONCLUSIONS: Frailty trajectories differ as a function of age-at-death category. The current level of FI is a stronger marker for risk stratification than the rate of change.
Place, publisher, year, edition, pages
Oxford University Press, 2021. Vol. 50, no 6, p. 2174-2182
Keywords [en]
age at death, frailty, mortality, older people, trajectories
National Category
Public Health, Global Health and Social Medicine
Research subject
Wellbeing in long-term health problems (WeLHP)
Identifiers
URN: urn:nbn:se:his:diva-20870DOI: 10.1093/ageing/afab106ISI: 000743035600059PubMedID: 34120182Scopus ID: 2-s2.0-85120159344OAI: oai:DiVA.org:his-20870DiVA, id: diva2:1632778
Funder
NIH (National Institute of Health), R01 AG04563NIH (National Institute of Health), R01 AG10175NIH (National Institute of Health), R01 AG028555NIH (National Institute of Health), R01 AG08861-09Forte, Swedish Research Council for Health, Working Life and Welfare, 97:0147:1BForte, Swedish Research Council for Health, Working Life and Welfare, 2009-0795Swedish Research Council, 825-2007-7460Swedish Research Council, 825-2009-6141Swedish Research Council, 521-2013-8689Swedish Research Council, 2015-03255Swedish Research Council, 2018-02077Swedish Research Council, 2016-03081Swedish Research Council, 2019-01272Swedish Research Council, 2015-06796Forte, Swedish Research Council for Health, Working Life and Welfare, 2013-2292Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
Note
CC BY-NC-ND 4.0
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Geriatrics Society
Address correspondence to: Juulia Jylhävä. Tel: 358-505351712. Email: juulia.jylhava@ki.se
Declaration of Sources of Funding: National Institutesof Health (grant numbers R01 AG04563, AG10175,AG028555, AG08861-09); the MacArthur Foundation Research Network on Successful Aging; the Swedish Council for Working Life and Social Research (FAS/FORTE) (grant numbers 97:0147:1B to N.L.P., 2009-0795 toN.L.P.); the Swedish Research Council (grant numbers 825-2007-7460, 825-2009-6141, 521-2013-8689, 2015-03255, 2018-02077 to J.J., 2016-03081, 2019-01272 to S.H.); JPND/Swedish Research Council (2015-06796 to N.L.P.); FORTE (2013-2292 to N.L.P.); the Loo & Hans Osterman Foundation to S.H. and J.J.; the Foundation for Geriatric Diseases to S.H.; the Magnus Bergwall Foundation to S.H.; the Strategic Research Program in Epidemiology at Karolinska Institutet to S.H. and J.J. and the King Gustaf V’s and Queen Victoria’s Freemason Foundation to S.H. and China Scholarship Council to G.B. and X.L. The financial sponsors had no role in the design, execution, analysis andinterpretation of data, or writing of the study.
2022-01-272022-01-272025-09-29Bibliographically approved